Tue, Mar

  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

- "This animal study shows the potential promise of this cell line in treating post-stroke symptoms,"
- "Four weeks after transplantation, the rats treated with Neuralstem's cells showed significantly decreased asymmetric body swing, increased vertical movements and increased grip strength, compared with the control group."

"Dr. Lin's findings represent a significant milestone for Neuralstem. They are the first to show how our human spinal cord-derived stem cell product, NSI-566RSC, currently in a clinical trial for ALS, and which we expect to be in another clinical trial for spinal cord injury, also works in the stroke brain,"

Neuralstem stem cells survive and differentiate into neurons in rats with stroke